Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma

• Published in: Hematology (Luxembourg) Vol. 28; no. 1; p. 2161215
• Main Authors: Yazer, Mark H., Panko, Gleb, Holcomb, John B., Kaplan, Alesia, Leeper, Christine, Seheult, Jansen N., Triulzi, Darrell J., Spinella, Philip C.
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 31.12.2023; Taylor & Francis Group
• Subjects: alloimmunization; emergency; Hemolytic disease of the fetus and newborn (HDFN); LTOWB; RBC; RhD; transfusion; trauma; trauma; RBC; LTOWB; emergency; transfusion; Hemolytic disease of the fetus and newborn (HDFN); alloimmunization; RhD
• ISSN: 1607-8454; 1607-8454
• DOI: 10.1080/16078454.2022.2161215

The use of blood products to resuscitate injured and massively bleeding patients in the prehospital and early in-hospital phase of the resuscitation is increasing. Using group O red blood cells (RBC) and low titer group O whole blood (LTOWB) avoids an immediate hemolytic reaction from recipient's naturally occurring anti-A and - B, but choosing the RhD type for these products is more nuanced and requires the balancing of product availability and survival benefit against the risk of D-alloimmunization, especially in females of childbearing potential (FCP) due to the possible future occurrence of hemolytic disease of the fetus and newborn (HDFN). Recent models have estimated the risk of fetal/neonatal death from HDFN resulting from D-alloimmunization of an FCP during her trauma resuscitation at between 0-6.5% depending on her age at the time of the transfusion and other societal factors including trauma mortality, her age when she becomes pregnant, frequency of different RHD genotypes in the population, and the probability that the woman will have children with different fathers; this is counterbalanced by an approximately 24% risk of death from hemorrhagic shock. This review will discuss the different models of HDFN outcomes following RhD-positive transfusion as well as the results of recent surveys where the public was asked about their preferences for urgent transfusion in light of the risks of fetal/neonatal adverse events.